AW
BMRN icon

Avion Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Avion Wealth’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
18
+1
+6% +$58 ﹤0.01% 979
2025
Q4 		$1K Sell
17
-33
-66% -$1.8K ﹤0.01% 980
2025
Q3 		$2K Buy
50
+14
+39% +$801 ﹤0.01% 829
2025
Q2 		$1K Buy
36
+10
+38% +$589 ﹤0.01% 917
2025
Q1 		$1K Hold
26
– – ﹤0.01% 817
2024
Q4 		$1K Sell
26
-15
-37% -$1K ﹤0.01% 814
2024
Q3 		$2K Buy
41
+28
+215% +$2.34K ﹤0.01% 657
2024
Q2 		$1K Sell
13
-5
-28% -$416 ﹤0.01% 689
2024
Q1 		$2K Sell
18
-5
-22% -$448 ﹤0.01% 642
2023
Q4 		$2K Buy
23
+17
+283% +$1.5K ﹤0.01% 536
2023
Q3 		$0 Sell
6
-4
-40% -$356 ﹤0.01% 826
2023
Q2 		$0 Buy
+10
New +$941 ﹤0.01% 729

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return